The well-known pathological markers of Alzheimer’s disease (AD) are extracellular amyloid beta peptide (Aβ peptide) plaques and intracellular neurofibrillary tangles (NFTs) of hyperphosphorylated Tau (22). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.